Quality of Life Good After Salvage Nasopharyngectomy

This article originally appeared here.
Share this content:
Quality of Life Good After Salvage Nasopharyngectomy
Quality of Life Good After Salvage Nasopharyngectomy

(HealthDay News) – For patients with residual or recurrent nasopharyngeal carcinoma who undergo salvage nasopharyngectomy using a maxillary swing approach, postoperative quality of life is generally good, according to a study published in the Aug. 1 issue of Cancer.

Yu Wai Chan, MD, of the University of Hong Kong Medical Center, and colleagues conducted a prospective, longitudinal study of 185 consecutive patients who underwent salvage nasopharyngectomy using a maxillary swing approach for residual or recurrent nasopharyngeal carcinoma, between 2003 and 2011. Quality of life was assessed using a self-reported, health-related quality-of-life questionnaire.

The researchers found that curative resection was achieved in 80% of patients. After surgery, there were no significant changes observed in the mean global health system scores, except after palliative resection requiring postoperative adjuvant chemoradiation. In all patient groups, social functioning scores were the lowest of the 5 functioning scales. Palatal fistula was found to have a significant effect on social eating and weight loss, while osteoradionecrosis caused more pain and nasal discharge and had a severe impact on social life.

"In conclusion, our current results indicate that the quality of life is good for patients after salvage nasopharyngectomy using the maxillary swing approach," the authors write. "Attention should be paid to achieving curative resection as much as possible and, at the same time, avoiding complications like trismus, palatal fistula, and osteoradionecrosis after surgery."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs